Williams Patrick F.
SEC insider (Form 3/4/5 filer). CIK 0001562229. Chief Financial Officer at NeuroPace Inc (NPCE) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Sep 20, 2026. Located in MOUNTAIN VIEW, CA.
Companies Williams Patrick F. has filed insider reports for
- NeuroPace Inc (NPCE): Officer, Chief Financial Officer
- STAAR SURGICAL CO (STAA): Officer, Chief Financial Officer
- BioRestorative Therapies, Inc. (BRTX): Director
Williams Patrick F.
CIK: 0001562229
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)4 (50.0%)
Derivative conversions
Awards (A)3 (37.5%)
Compensation grants
Other (G, F, J, C, D, …)1 (12.5%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Sep 20, 2026NPCE
NeuroPace Inc
Tax PaymentDirect1.2K shares at avg. $14.28$17K - May 15, 2026NPCE
NeuroPace Inc
AwardDirect16.8K shares- - Jun 20, 2025NPCE
NeuroPace Inc
AwardDirect51.9K shares- - Mar 12, 2025STAA
STAAR SURGICAL CO
ExerciseDirect8.2K shares- - Mar 10, 2025STAA
STAAR SURGICAL CO
ExerciseDirect4.1K shares- - Mar 7, 2025STAA
STAAR SURGICAL CO
ExerciseDirect2.6K shares- - Mar 7, 2025STAA
STAAR SURGICAL CO
ExerciseDirect3.1K shares- - Feb 14, 2025BRTX
BioRestorative Therapies, Inc.
AwardDirectStock Option
52.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 20, 2026 |  NPCE NeuroPace Inc | Tax Payment | 1,162 | $14.28 | $16,593 | Direct |
| May 15, 2026 | NPCE NeuroPace Inc | Award | 16,820 | - | $0 | Direct |
| Jun 20, 2025 | NPCE NeuroPace Inc | Award | 51,850 | - | - | Direct |
| Mar 12, 2025 |  STAA STAAR SURGICAL CO | Exercise | 8,153 | - | - | Direct |
| Mar 10, 2025 | STAA STAAR SURGICAL CO | Exercise | 4,061 | - | - | Direct |
| Mar 7, 2025 | STAA STAAR SURGICAL CO | Exercise | 2,614 | - | - | Direct |
| Mar 7, 2025 | STAA STAAR SURGICAL CO | Exercise | 3,075 | - | - | Direct |
| Feb 14, 2025 |  BRTX BioRestorative Therapies, Inc. | Award Stock Option | 52,632 | - | - | Direct |
1-8 of 8 transactions